Restless legs syndrome (RLS) - an irresistible urge to move one's
legs that occurs even while a person is asleep - is common but
poorly understood. Among 169,000 healthy patients included in the
analysis, some 24,000 had been diagnosed with RLS. Over a six-year
follow-up, those with RLS were over two and a half times as likely
as those without it to harm themselves or experience suicidal
thinking or attempts, researchers report in JAMA Network Open.
"RLS is one of the most common sleep disorders and movement
disorders, affecting about 5% of U.S. adults," said senior study
author Dr. Xiang Gao of the Pennsylvania State University College of
Medicine in University Park.
RLS is considered a neurologic disorder. It has been associated with
disturbed sleep and with depression, the study team notes.
"We've also published several studies that show RLS is associated
with a high risk of developing depression," Gao noted in an email.
With U.S. suicide rates rising, Gao and colleagues wanted to explore
links between RLS and suicide risk. They analyzed national health
claims data from 2006-2014 for adults enrolled in U.S. commercial
medical, pharmacy and dental insurance plans. Along with 24,000
people with a diagnosis of RLS, they included 145,000 similar people
without RLS. All 169,000 individuals had no history of heart
disease, cancer, self-harm or suicidal thinking at the beginning of
the study.
The researchers found that people with RLS were more likely to be
diagnosed with depression and to use antidepressant medicines, which
could suggest poorer mental health. Individuals with RLS were also
more likely to live in a rural area, to consume alcohol, to have
chronic obstructive pulmonary disease and to report other chronic
conditions such as diabetes, hypertension, sleep apnea, insomnia,
kidney disease and neurological disorders.
There were 119 suicide and self-harm cases during the study. After
researchers accounted for other factors that could influence
self-harm and suicide risk, including alcohol abuse, obesity,
depression, insomnia and diabetes, they found that people with RLS
were 2.66 times more likely as those without RLS to be among these
cases.
The higher risk of suicide and self-harm was present among people
with an RLS diagnosis who were receiving treatment for the syndrome
and those not receiving a prescribed treatment.
[to top of second column] |
When researchers excluded people with depression, insomnia,
obstructive sleep apnea and chronic medication use from their
calculations, the association between RLS and suicide or self-harm
not only persisted, it grew in strength to a more than four-fold
risk with RLS, the authors note.
"It suggests that RLS, per se, could be a risk factor for suicide or
self-harm, independent of depression and sleep disorders which are
commonly seen among RLS patients," Gao said.
The study wasn't designed to determine how RLS might directly or
indirectly contribute to risks for suicidal thinking or self-harm.
And medical insurance claims data may miss people with undiagnosed
RLS and those with undiagnosed suicidal or self-harm episodes, the
study team notes.
"RLS has annoying symptoms that patients can't stand. However,
because it's not well-known to folks, even among clinicians, it can
be misdiagnosed and treated the wrong way," said Dr. Heon-Jeong Lee
of the Korea University College of Medicine in Seoul, who wasn't
involved in the study.
"RLS symptoms and mental distress are more likely to worsen if you
increase the amount of drugs to treat symptoms such as insomnia and
depression," Lee told Reuters Health by email.
RLS tends to disrupt the circadian rhythm, Lee added, which
compounds the symptoms. Lifestyle changes such as getting regular
exercise can often help people get better sleep by tiring them out.
"Above all, having a regular lifestyle rhythm is important to
prevent the aggravation of RLS," Lee said. "Symptoms of mild RLS are
not a problem if the sleep needs increase due to sufficient activity
during the day."
SOURCE: https://bit.ly/2ZDiEAp JAMA Network Open, online August 23,
2019.
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|